SEMALIX 14MG – Semaglutide 14mg

SEMALIX 14MG contains Semaglutide 14mg, an oral GLP-1 receptor agonist manufactured by Torrent Pharmaceuticals Ltd. It is a prescription medicine used to improve blood-glucose control in adults with insufficiently controlled type 2 diabetes mellitus, together with diet and exercise.

Semaglutide mimics the action of the naturally occurring hormone GLP-1. It helps regulate blood glucose by increasing insulin secretion when blood glucose is elevated, reducing glucagon secretion and producing a modest delay in gastric emptying. Semaglutide can also reduce appetite and food intake, and weight may decrease in some patients during treatment.

SEMALIX 14MG is not the starting dose. Treatment generally begins with 3mg once daily, followed by 7mg and, when additional glycemic control is required and tolerated, 14mg. The manufacturer’s prescribing information identifies 14mg once daily as the maximum recommended daily dose for the oral tablet.

Key Product Information

How Semalix Works

Semaglutide activates GLP-1 receptors, helping to:

• Increase insulin secretion when blood glucose is elevated
• Reduce glucagon secretion
• Slow gastric emptying
• Reduce appetite and food intake

These effects help improve blood-glucose control and may contribute to reduced body weight in some patients.

How to Take

• Take once daily on an empty stomach.
• Take it when you first wake up.
• Swallow the tablet whole with a small amount of plain water, up to approximately 120 mL (4 ounces).
• Do not crush, chew or split the tablet.
• Wait at least 30 minutes before eating, drinking anything other than plain water, or taking other oral medicines.